Inhibition of NAMPT sensitizes MOLT4 leukemia cells for etoposide treatment through the SIRT2-p53 pathway.

MLA

Grohmann, Theresa, et al. “Inhibition of NAMPT Sensitizes MOLT4 Leukemia Cells for Etoposide Treatment through the SIRT2-P53 Pathway.” Leukemia Research, vol. 69, June 2018, pp. 39–46. EBSCOhost, https://doi.org/10.1016/j.leukres.2018.04.004.

APA

Grohmann, T., Penke, M., Petzold-Quinque, S., Schuster, S., Richter, S., Kiess, W., & Garten, A. (2018). Inhibition of NAMPT sensitizes MOLT4 leukemia cells for etoposide treatment through the SIRT2-p53 pathway. Leukemia Research, 69, 39–46. https://doi.org/10.1016/j.leukres.2018.04.004

Chicago

Grohmann, Theresa, Melanie Penke, Stefanie Petzold-Quinque, Susanne Schuster, Sandy Richter, Wieland Kiess, and Antje Garten. 2018. “Inhibition of NAMPT Sensitizes MOLT4 Leukemia Cells for Etoposide Treatment through the SIRT2-P53 Pathway.” Leukemia Research 69 (June): 39–46. doi:10.1016/j.leukres.2018.04.004.